Biogen shares surge after MS drug study
April 21, 2011 at 11:24 AM EDT
Positive data for Biogen’s new MS drug send shares of that company soaring while pushing down shares of competitors Teva and Elan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.